The following information is based on a press release from Novo Nordisk A/S
(Novo Nordisk) dated October 31, 2013 and may be subject to change.
The board of Novo Nordisk has decided on a stock split whereby every share will be replaced by five new shares (5:1). The Ex-date is January 2, 2014. NASDAQ OMX Derivatives Markets will carry out a re-calculation of options and futures in Novo Nordisk (NOVOB).
For further information, please see the attached file.
Attachment:
https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=449339
The board of Novo Nordisk has decided on a stock split whereby every share will be replaced by five new shares (5:1). The Ex-date is January 2, 2014. NASDAQ OMX Derivatives Markets will carry out a re-calculation of options and futures in Novo Nordisk (NOVOB).
For further information, please see the attached file.
Attachment:
https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=449339
© 2013 GlobeNewswire
